Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$3.28 - $4.81 $2.3 Million - $3.37 Million
700,000 Added 15.91%
5,100,929 $17.6 Million
Q3 2021

Nov 12, 2021

BUY
$5.18 - $7.41 $3.11 Million - $4.45 Million
600,929 Added 15.81%
4,400,929 $31.7 Million
Q2 2021

Aug 13, 2021

BUY
$3.94 - $6.75 $2.36 Million - $4.05 Million
599,537 Added 18.73%
3,800,000 $25.1 Million
Q1 2021

May 19, 2021

BUY
$4.03 - $7.25 $4.9 Million - $8.81 Million
1,215,463 Added 61.23%
3,200,463 $13.9 Million
Q4 2019

Feb 18, 2020

BUY
$2.3 - $4.6 $2.42 Million - $4.83 Million
1,050,000 Added 112.3%
1,985,000 $8.38 Million
Q3 2019

Nov 14, 2019

SELL
$2.9 - $9.56 $2.73 Million - $8.99 Million
-940,809 Reduced 50.15%
935,000 $2.71 Million
Q2 2019

Aug 15, 2019

BUY
$6.7 - $9.13 $1.94 Million - $2.65 Million
290,000 Added 18.29%
1,875,809 $16.5 Million
Q1 2019

May 15, 2019

BUY
$5.7 - $8.73 $2.05 Million - $3.14 Million
360,216 Added 29.39%
1,585,809 $11.7 Million
Q4 2018

Feb 14, 2019

BUY
$5.04 - $10.28 $6.18 Million - $12.6 Million
1,225,593 New
1,225,593 $7.44 Million

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track This Portfolio

Track Bamco Inc Portfolio

Follow Bamco Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.